BALCHEM CORP·4

Feb 13, 4:15 PM ET

Wineinger Matthew David 4

4 · BALCHEM CORP · Filed Feb 13, 2026

Research Summary

AI-generated summary of this filing

Updated

Balchem (BCPC) Director Matthew Wineinger Receives 870-Share Award

What Happened
Matthew David Wineinger, a director of Balchem Corp (BCPC), received an award of 870 restricted shares on February 11, 2026. The grant is reported at an acquisition price of $0.00 (total $0) — this is a restricted stock award, not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-02-11 (reported on Form 4 filed 2026-02-13). The filing appears timely under Form 4 reporting rules.
  • Transaction type/code: Award/Grant (A).
  • Shares granted: 870; reported acquisition price: $0.00 (total $0).
  • Shares owned after transaction: not disclosed in the filing.
  • Footnote: Ownership of the restricted stock vests one year after the grant date and remains subject to transfer restrictions per the Restricted Stock Grant Agreement.

Context
Restricted stock awards are a form of compensation and typically vest over time; they do not indicate an immediate buy or sell market action. The $0 acquisition price reported reflects the grant reporting convention — the economic value depends on Balchem’s market price at vesting or sale and any applicable tax/tax-withholding events that may occur at vesting.

Insider Transaction Report

Form 4
Period: 2026-02-11
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-11+8708,012 total
Footnotes (1)
  • [F1]Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restrictions of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
Signature
/s/ Travis Larsen, Attorney in Fact for Matthew David Wineinger|2026-02-13

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4